Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Vittorio Maglione (@VittorioMaglio1) / Twitter
Telethon finanzia la ricerca sulle malattie rare della Fondazione Neuromed - Istituto Neuromed
NEUROMED INCONTRA PAPA FRANCESCO | inSalute – Neuromed
Telethon finanzia la ricerca Neuromed: Vittorio Maglione, lab malattie rare - YouTube
Ricercatore Neuromed relatore al corso avanzato della FEBS - Istituto Neuromed
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
PDF) The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington's disease
Ricerca Neuromed. Individuata una strada innovativa per la Malattia di Huntington - Istituto Neuromed
Frontiers | Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders | Neuroscience
PDF) Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course
Frontiers | De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease | Neuroscience
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Loop | Vittorio Maglione
Malattie rare, intervista a Vittorio Maglione ricercatore Neuromed - Adnkronos.com
Il ricercatore Vittorio Maglione alla prestigiosa Gordon Conference – quotidianomolise.com
vittorio maglione - Country manager Italia - Alliance Laundry System | LinkedIn
Pozzilli: Vittorio Maglione , ricercatore del Neuromed invitato alla Gordon Conference. Presenterà i suoi lavori sui glicolipidi e sfingolipidi. - News Della Valle
NEUROMED - Il ricercatore Vittorio Maglione relatore al corso della Federazione Europea delle Società Biochimiche | Molise Network
Vittorio Maglione | Neurology Conferences 2018 | Neuroscience Conferences | Neurology Congress 2018
Neurology Conferences 2022 | Neuroscience Conferences | Brain Disorders Conference 2022 | Brain Congress 2022 | Neurology Events 2022
PDF) Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
Vittorio Maglione (@VittorioMaglio1) / Twitter
Vittorio MAGLIONE | Group Leader | PhD | IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli | Neuromed | Centre for Neurogenetics and Rare Diseases
